RecruitingNot ApplicableNCT05433220

PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova

PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure (PROMPT-HF) at Inova

Sponsor

Inova Health Care Services

Enrollment

5,000 participants

Start Date

Aug 25, 2022

Study Type

INTERVENTIONAL

Conditions

Heart Failure

Summary

A randomized, single-blind intervention trial to test the comparative effectiveness of an electronic health record best practice advisory system that informs clinicians of guideline-indicated and FDA-approved heart failure medications currently not prescribed to their patients with heart failure versus usual care (no alert and how things are done currently). The purpose of the alert is to stimulate appropriate medication prescription for patients with heart failure and a reduced ejection fraction. This will be done across outpatient Inova clinics and at the five Inova hospitals.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Age\>18 Years
Seen by a Cardiologist in an Inova clinic or Inova hospital setting
Left Ventricular Ejection Fraction ≤40%

Exclusion Criteria4

Opted out of EHR-based research
Hospice care
Already receiving maximally titrated doses of each of the four classes of evidence- based HFrEF medical therapy
Prior heart transplant

Interventions

OTHERBest Practice Advisory using Electronic Health Record

Providers caring for patients randomized to the intervention arm will have a best practice alert appear for each of their eligible patients upon opening of the order entry screen in the patient's medical record. This alert informs the provider to the presence of HFrEF, notes the patient's current LVEF and current evidence-based medications, and gives access to an order set with recommended evidence- based, guideline-recommended, and FDA- approved therapies for patients with HFrEF. Providers will also have access to a link to best available guideline recommended information regarding treatment of heart failure to allow further education if desired by the provider. The alerts will also clearly state the expected monitoring and follow-up required for prescriptions of these medications.